HOME >> BIOLOGY >> NEWS
Scientists find a way to detect which breast abnormalities may develop into cancer

Scientists at the Royal Liverpool University Hospitals in the UK have found a way of testing whether certain abnormalities in a womans breast are likely to go on to develop into breast cancer, the 3rd European Breast Cancer Conference in Barcelona heard today (Wednesday 20 March).

Armed with information from the test, doctors could then consider whether the at-risk women should be offered prophylactic anti-oestrogen treatment such as tamoxifen or more frequent screening.

However, Dr Abeer M. Shaaban, a Specialist Registrar in the hospitals department of Cellular and Molecular Pathology, warned that, while the test itself was fairly straightforward to do, it might be many years before it could lead to the development of prophylactic treatments, especially as clinical trials are still being run to test the effectiveness of anti-oestrogens such as tamoxifen in preventing breast cancer.

Hyperplasia of usual type (HUT) is a benign abnormality in the breast. Although it is formed by cell proliferation, it is not cancer, but it is associated with a slightly increased risk of cancer developing subsequently. Women who have HUT have a risk of developing breast cancer of between 1.5 and 2 times that of the general population. Normally HUT cannot be detected by self-examination, and is usually spotted during screening and diagnosed following a biopsy.

Dr. Shaaban, working with Professor Christopher S. Foster, head of the hospitals Pathology Laboratories, studied 674 biopsies from a 20-year period between 1979 and 1999 to see whether those samples that belonged to patients who had subsequently developed breast cancer contained different biological signals to samples from women who did not develop cancer. The biopsies included cases from 120 women who subsequently developed cancer and 382 who did not during the 20-year follow-up.

She found that in samples from women who had developed breast cancer subsequently, there was a high propo
'"/>

Contact: Emma Mason
wordmason@aol.com
44-0-7711-296-986
Federation of European Cancer Societies
20-Mar-2002


Page: 1 2

Related biology news :

1. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
2. Scientists sequence genome of kind of organism central to biospheres carbon cycle
3. Scientists find nanowires capable of detecting individual viruses
4. Scientists discover potential new way to control drug-resistant bacteria
5. Scientists explore genome of methane-breathing microbe
6. Scientists decipher genetic code of biothreat pathogen
7. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
8. Scientists discover proteins involved in spread of HIV-1 infection
9. Scientists fear new Ebola outbreak may explain sudden gorilla disappearance
10. Scientists reinvent DNA as template to produce organic molecules
11. Scientists visualise cellular handmaiden that restores shape to proteins

Post Your Comments:
(Date:7/23/2014)... drought that has the entire country in its grip is ... also be responsible for the proliferation of a heat-loving amoeba ... and hot springs, which the drought has made warmer than ... of an infection caused by this parasite after swimming in ... nose of an individual and travels to the brain. Nose ...
(Date:7/23/2014)... The Worldwide Innovative Networking in personalized cancer medicine, ... Cancer Center at Thomas Jefferson University will ... only member of this prestigious group in the Tri-State ... delivery of innovative personalized medicine to the patient by ... advocacy. , "Our participation in the WIN consortium means ...
(Date:7/23/2014)... play an increasingly important role in carbon and nutrient ... expand, according to research published this week in the ... , University of British Columbia researchers plumbed the depth ... chart how microbial community metabolism changes as oxygen minimum ... picture of how SUP05 a bacterial group related ...
Breaking Biology News(10 mins):Diseases of another kind 2New partnership brings more personalized cancer treatment to Philadelphia 2Research charts the ecological impact of microbial respiration in the oxygen-starved ocean 2
(Date:7/23/2014)... the right people at the table for significant business ... achieving clinical and operational goals. The 22 nd ... 2014, in San Diego , featured ... discussing how partnerships have positively impacted their objectives. ... Officer of Cape Regional Medical Center located in ...
(Date:7/23/2014)... , July 23, 2014 ... portfolio company of Trendlines Agtech , announced ... Israel,s leading agricultural thermoplastics ... Valentis,s technology combines nanocrystalline cellulose (NCC), ... waste, with additional nanoparticles to produce highly improved ...
(Date:7/23/2014)... -- regulated information -- UCB today announced an important ... positive topline results from the latest Phase 3 ... to evaluate the efficacy and safety of ... compared to placebo, as adjunctive treatment in adult ... controlled despite treatment with one or two concomitant ...
(Date:7/23/2014)... July 23, 2014  Sofinnova Ventures, a ... the closing of Sofinnova Venture Partners IX, L.P. at ... of the initial fund target of $425 million. ... biotechnology companies. Consistent with recent funds, SVP IX will ... clinical programs, along with select investments in earlier stage ...
Breaking Biology Technology:MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2
Cached News: